Skip to main content

Table 3 Cancer-related associations for use of CAM to treat late and long-term effects from cancer diagnosis and treatment

From: Prevalence of late and long-term effects of cancer (treatment) and use of complementary and alternative medicine in Norway

 

Total CAM use

CAM provider

Natural remedies

Self-help practices

% (n = 153)

% (n = 207)

p-value

% (n = 80)

% (n = 207)

p-value

% (n = 47)

% (n = 313)

p-value

% (n = 95)

% (n = 265)

p-value

Cancer site1

Yes

No

 

Yes

No

 

Yes

No

 

Yes

No

 

 Breast

58.2 (85)

41.8 (61)

< 0.001*

35.6 (52)

64.4 (94)

< 0.001*

13.7 (20)

86.3 (126)

0.765*

39.0 (57)

61.0 (89)

< 0.001*

 Gastro intestinal

25.0 (12)

75.5 (36)

0.008*

8.3 (4)

91.7 (44)

0.013*

14.6 (7)

85.4 (41)

0.736*

18.8 (9)

81.3 (39)

0.197*

 Male genitalia

25.0 (9)

75.0 (27)

0.025*

8.3 (3)

91.7 (33)

0.035*

8.3 (3)

91.7 (33)

0.600^

11.1 (4)

88.9 (32)

0.028*

 Female genitalia

58.8 (20)

41.2 (14)

0.043*

29.4 (10)

70.6 (24)

0.289*

20.6 (7)

79.4 (27)

0.181^

44.1 (15)

55,9 (19)

0.014*

 Lymphoma

27.3 (9)

72.7 (24)

0.063*

12.1 (4)

87.9 (29)

0.143*

6.1 (2)

93.9 (31)

0.284^

15.2 (5)

84,8 (28)

0.124*

 Head and neck

52.9 (9)

47.1 (8)

0.372*

17.6 (3)

82.4 (14)

0.773^

17.6 (3)

82.4 (14)

0.474^

29.4 (5)

70,6 (12)

0.780^

 Malignant melanoma

28.6 (4)

71.4 (10)

0.282*

21.4 (3)

78.6 (11)

1.000^

0.0 (0)

100 (14)

0.231^

14.3 (2)

85,7 (12)

0.371^

 Lung

36.4 (4)

63.6 (7)

0.765^

18.2 (2)

81.8 (9)

1.000^

27.3 (3)

72.7 (8)

0.162^

9.1 (1)

90,9 (10)

0.300^

 Sarcoma

63.6 (7)

36.4 (4)

0.215^

36.4 (4)

63.6 (7)

0.271^

27.3 (3)

72.7 (8)

0.162^

36.4 (4)

63,6 (7)

0.490^

 Leukemia

0.0 (0)

100 (9)

0.012^

0.0 (0)

100 (9)

0.216^

0.0 (0)

100 (9)

0.612^

0.0 (0)

100 (9)

0.119^

 Bone marrow

25.0 (2)

75.0 (6)

0.475^

25.0 (2)

75.0 (6)

1.000^

12.5 (1)

87.5 (7)

1.000^

0.0 (0)

100 (8)

0.116^

 Other cancer sites

32.6 (14)

67.4 (29)

0.160*

11.6 (4)

88.4 (38)

0.075*

14.0 (6)

86.0 (37)

0.852*

20.9 (9)

79.1 (34)

0.387*

In active cancer treatment

  

0.427*

  

0.425*

  

0.144*

  

0.039*

 Yes

39.7 (50)

60.3 (7)

 

24.6 (31)

75.4 (95)

 

9.5 (12)

90.5 (114)

 

19.8 (25)

80.2 (101)

 

 No

44.0 (103)

56.0 (131)

 

20.9 (49)

79.1 (185)

 

15.0 (35)

85.0 (199)

 

29.9 (70)

70.1 (164)

 

Late and long-term effects

 Fatigue

47.5 (122)

52.5 (135)

0.003*

24.1 (62)

75.9 (195)

0.170*

13.6 (35)

86.4 (222)

0.616*

31.1 (80)

68.9 (177)

0.001*

 Sleep disorder

53.3 (96)

46.7 (84)

< 0.001*

28.9 (52)

71.1 (128)

0.002*

15.6 (28)

84.4 (152)

0.159*

32.8 (59)

67.2 (121)

0.006*

 Hot flashes

55.3 (94)

44.7 (76)

< 0.001*

30.0 (51)

70.0 (119)

< 0.001*

17.1 (29)

82.9 (141)

0.033*

35.9 (61)

64.1 (109)

< 0.001*

 Nerve damage (polyneuropathy)

52.7 (87)

47.3 (78)

< 0.001*

26.7 (44)

73.3 (121)

0.062*

14.5 (24)

85.8 (141)

0.440*

35.8 (59)

64.2 (106)

< 0.001*

 Pain

54.1 (86)

45.9 (73)

< 0.001*

30.2 (48)

69.8 (111)

0.001*

15.1 (24)

84.9 (135)

0.307*

35.8 (57)

64.2 (102)

< 0.001*

 Decreased muscle strength and mobility

52.5 (83)

47.5 (75)

< 0.001*

30.4 (48)

69.6 (110)

< 0.001*

15.8 (25)

84.2 (133)

0.168*

32.9 (52)

67.1 (106)

0.013*

 Cognitive challenges

63.1 (94)

36.9 (55)

< 0.001*

34.2 (51)

65.8 (98)

< 0.001*

17.4 (26)

82.6 (123)

0.038*

14.6 (62)

58.4 (87)

< 0.001*

 Sexual problems

46.7 (64)

53.5 (73)

0.205*

24.1 (33)

75.9 (104)

0.505*

15.3 (21)

84.7 (116)

0.316*

29.2 (40)

70.8 (97)

0.343*

 Gained weight

53.4 (63)

46.6 (55)

0.004*

32.2 (38)

67.8 (80)

0.001*

16.9 (20)

83.1 (98)

0.126*

30.5 (36)

69.5 (82)

0.216*

 Anxiety or depression

55.2 (53)

44.8 (43)

0.003*

30.2 (29)

69.8 (67)

0.028*

15.6 (15)

84.4 (81)

0.383*

36.5 (35)

63.5 (61)

0.009*

 Early menopause

66.7 (60)

33.3 (30)

< 0.001*

41.1 (37)

58.9 (53)

< 0.001*

16.7 (15)

83.3 (75)

0.240*

48.9 (44)

51.1 (46)

< 0.001*

 Mouth/tooth-problems and reduced taste

56.0 (47)

44.0 (37)

0.004*

31.0 (26)

69.0 (58)

0.028*

14.3 (12)

85.7 (72)

0.702*

28.6 (24)

71.4 (60)

0.604*

 Urinary tract problems

42.3 (33)

57.7 (45)

0.969*

20.5 (16)

79.5 (62)

0.682*

14.1 (11)

85.9 (67)

0.756*

26.9 (21)

73.1 (57)

0.904*

 Diarrhea

52.6 (41)

47.4 (37)

0.042*

26.9 (21)

73.1 (57)

0.259*

16.7 (13)

83.3 (65)

0.285*

33.3 (26)

66.7 (52)

0.116*

 Constipation

52.8 (38)

47.2 (34)

0.049*

31.9 (23)

68.1 (49)

0.027*

18.1 (13)

81.9 (59)

0.159*

33.3 (24)

66.7 (48)

0.135*

 Lymphedema

55.4 (36)

44.6 (29)

0.020*

32.3 (21)

67.7 (44)

0.031*

15.4 (10)

84.6 (55)

0.538*

29.2 (19)

70.8 (46)

0.566*

 Heart- and lung problems

46.2(18)

53.8 (21)

0.625*

25.6 (10)

74.4 (29)

0.587*

20.5 (8)

79.5 (31)

0.143*

28.2 (11)

71.8 (28)

0.785*

 Reduced fertility

57.6 (19)

42.4 (14)

0.066*

27.3 (9)

72.7 (24)

0.464*

9.1 (3)

90.9 (30)

0.597^

36.4 (12)

63.6 (21)

0.173*

 Weight loss

40.0 (12)

60.0 (18)

0.772*

16.7 (5)

83.3 (25)

0.445*

6.7 (2)

93.3 (28)

0.399^

23.3 (7)

76.7 (23)

0.692*

Other late and long-term effects

35.4 (23)

64.6 (42)

0.200*

15.4 (10)

84.6 (55)

0.143*

16.9 (11)

83.1 (54)

0.307*

21.5 (14)

78.5 (51)

0.327*

  1. *Pearson chi-square test
  2. ^Fisher exact test
  3. 1As some participants might have been diagnosed with more than one cancer form the total number of cancer sites extend the number of participants in the study